Description
A potent and noncompetitive inhibitor of MAGL (IC50 = 200 nM for the recombinant rat brain enzyme); inhibits rat brain FAAH (IC50 = 32 µM); binds weakly to the rat CB1 receptor (IC50 = 3.8 µM); does not inhibit COX-1 or COX-2 at concentrations up to 100 µM
Formal name: 6-methyl-2-[(4-methylphenyl)amino]-1-benzoxazin-4-one
Synonyms:
Molecular weight: 266.3
CAS: 86672-58-4
Purity: >98%
Formulation: A crystalline solid
Application||Product Type|Biochemicals|Receptor Pharmacology||Product Type|Biochemicals|Small Molecule Inhibitors|Fatty Acid Metabolism||Product Type|Biochemicals|Small Molecule Inhibitors|Glycerolipid Lipases||Research Area|Lipid Biochemistry|Endocannabinoid/Endocannabinoid-like||Research Area|Lipid Biochemistry|Glycerolipids|Lipases||Research Area|Neuroscience|Cannabinoid Research|CB1 & CB2 Receptors||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids||Research Area|Neuroscience|Pain Research